These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 14529542)

  • 1. Novel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents.
    Nair V
    Curr Pharm Des; 2003; 9(31):2553-65. PubMed ID: 14529542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV integrase as a target for antiviral chemotherapy.
    Nair V
    Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV integrase inhibitors as therapeutic agents in AIDS.
    Nair V; Chi G
    Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C; Bailly F; Cotelle P
    Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
    Taktakishvili M; Neamati N; Pommier Y; Nair V
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1433-5. PubMed ID: 11378371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors.
    Xu YW; Zhao GS; Shin CG; Zang HC; Lee CK; Lee YS
    Bioorg Med Chem; 2003 Aug; 11(17):3589-93. PubMed ID: 12901903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer tools in the discovery of HIV-1 integrase inhibitors.
    Liao C; Nicklaus MC
    Future Med Chem; 2010 Jul; 2(7):1123-40. PubMed ID: 21426160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in diketo-containing inhibitors of HIV-1 integrase.
    Zhao G; Wang C; Liu C; Lou H
    Mini Rev Med Chem; 2007 Jul; 7(7):707-25. PubMed ID: 17627583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting HIV-1 integrase with strand transfer inhibitors.
    Li Y; Xuan S; Feng Y; Yan A
    Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diketoacid chelating ligands as dual inhibitors of HIV-1 integration process.
    Rogolino D; Carcelli M; Compari C; De Luca L; Ferro S; Fisicaro E; Rispoli G; Neamati N; Debyser Z; Christ F; Chimirri A
    Eur J Med Chem; 2014 May; 78():425-30. PubMed ID: 24704615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds].
    Yu SH; Tan YM; Zhao GS
    Yao Xue Xue Bao; 2010 Feb; 45(2):215-23. PubMed ID: 21351431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
    Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors.
    Meadows DC; Mathews TB; North TW; Hadd MJ; Kuo CL; Neamati N; Gervay-Hague J
    J Med Chem; 2005 Jul; 48(14):4526-34. PubMed ID: 15999991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
    Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.